News for UCB S.A. (UNC.MU)

Published at

Mar 4, 2021 8:21 AM

by rttnews.com

mixed

mixed

KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent

Today's Daily Dose brings you news about KemPharm scoring regulatory nod for its ADHD drug, expanded FDA approval for Pfizer's Lorbrena, United Therapeutics scrapping the development of Trevyent, Vir Biotechnology closing the enrollment in VIR-7831 arm of ACTIV-3 trial, and Takeda securing global rights to Ovid's investigational medicine Soticlestat.

VIR UTHR UTH.SG UTH.MU UTH.F UTH.BE RMN.F RMN.BE OVID OCGN MNOV KMPH GSK.L GSK GS7A.F GS7.SG GS7.MU GS7.F GS7.DE GS7.BE GLAXF 4875.T 2H51.F 2H51.BE 1OT.MU 1OT.F 1OT.BE UNC.MU UCBN.MX UCBJF SANA PFED.BA PFE.SG PFE.MX PFE.MU PFE.F PFE.DE PFE.BE PFE MGTA LHDX GHSI 3MT.MU 3MT.F 3MT.BE

Read more →